The Effect of Probiotics (MCP(®) BCMC(®) Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease

Treatment for non-alcoholic fatty liver disease (NAFLD) currently consists of lifestyle modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part of the gut–liver axis and serves as a potential target for NAFLD treatment. We investigated the effect of probiotics...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamad Nor, Mohamad Hizami, Ayob, Nurainina, Mokhtar, Norfilza M., Raja Ali, Raja Affendi, Tan, Geok Chin, Wong, Zhiqin, Shafiee, Nor Hamizah, Wong, Yin Ping, Mustangin, Muaatamarulain, Nawawi, Khairul Najmi Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468225/
https://www.ncbi.nlm.nih.gov/pubmed/34579068
http://dx.doi.org/10.3390/nu13093192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468225/
https://www.ncbi.nlm.nih.gov/pubmed/34579068
http://dx.doi.org/10.3390/nu13093192

Ejemplares similares